drugset / Trial / NCT06429501

Local Anesthesia for Facial Fractures

NCT06429501

Phase 2 Recruiting 70 enrolled Washington University School of Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is a double-blind randomized, placebo controlled trial examining the impact of perioperative bupivacaine nerve block on PACU recovery metrics. Patients with operative facial fractures are randomized to receive either bupivacaine or saline injections prior to the anesthesia emergence.

Timeline

Start
2024-04-02
Primary completion
2027-02-01
Completion
2027-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Background Epinephrine Other / unclassified

Indications

No indication recorded.